NYSE : INSP

Inspire Medical Systems, Inc. — Financial statements

Healthcare · Medical Devices · United States

Last price 68.1 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.97B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Inspire Medical Systems, Inc. (INSP) reported revenue of 898.74M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue898.74M911.98M802.80M624.80M407.86M233.39M
Cost of Revenue124.64M133.22M122.99M96.58M66.11M33.28M
Gross Profit774.11M778.76M679.82M528.22M341.74M200.12M
Selling, General & Admin620.30M624.64M529.61M451.96M320.69M202.62M
Research & Development99.68M103.17M114.13M116.54M68.64M37.35M
Operating Expenses719.98M727.80M643.74M568.49M389.33M239.97M
Operating Income54.12M50.95M36.08M-40.27M-47.59M-39.85M
Interest Expense-137.00K-137.00K-22.00K-1.68M-2.13M
Interest & Investment Income15.47M17.54M23.25M20.56M5.05M125.00K
Currency Exchange Gain (Loss)-1.00M-1.00M-900.00K-200.00K-100.00K
Other Non Operating Income (Expenses)-3.12M-1.66M45.00K5.00K51.00K-117.00K
Pretax Income69.38M65.70M58.45M-19.91M-44.27M-41.97M
Income Tax Expense-65.66M-79.72M4.94M1.25M613.00K72.00K
Net Income135.04M145.42M53.51M-21.15M-44.88M-42.04M
Net Income to Common135.04M145.42M53.51M-21.15M-44.88M-42.04M
Shares Outstanding (Basic)28.95M29.37M29.76M29.30M28.07M27.26M
Shares Outstanding (Diluted)29.34M29.76M30.54M29.30M28.07M27.26M
EPS (Basic)4.664.951.80-0.72-1.60-1.54
EPS (Diluted)4.614.891.75-0.72-1.60-1.54
Free Cash Flow117.09M78.48M91.12M1.02M2.47M-24.79M
Free Cash Flow Per Share3.992.642.980.040.09-0.91
Gross Margin86.13%85.39%84.68%84.54%83.79%85.74%
Operating Margin6.02%5.59%4.50%-6.44%-11.67%-17.07%
Profit Margin15.03%15.95%6.67%-3.39%-11.00%-18.01%
Free Cash Flow Margin13.03%8.61%11.35%0.16%0.61%-10.62%
EBITDA71.33M64.91M42.63M-37.42M-45.73M-38.63M
EBITDA Margin7.94%7.12%5.31%-5.99%-11.21%-16.55%
D&A For EBITDA17.21M13.96M6.55M2.85M1.86M1.22M
EBIT54.12M50.95M36.08M-40.27M-47.59M-39.85M
EBIT Margin6.02%5.59%4.50%-6.44%-11.67%-17.07%
Effective Tax Rate8.46%
Advertising Expenses114.90M94.90M100.30M74.30M47.80M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents127.76M104.81M150.15M185.54M441.59M214.47M
Short-Term Investments192.92M203.46M295.40M274.84M9.82M
Cash & Short-Term Investments320.68M308.27M445.55M460.38M451.41M214.47M
Receivables103.34M119.69M93.07M89.88M61.23M34.18M
Inventory170.45M145.29M80.12M33.88M11.89M17.23M
Prepaid Expenses14.20M10.40M12.07M9.60M5.50M2.66M
Total Current Assets608.67M583.65M630.81M593.74M530.03M268.54M
Property, Plant & Equipment126.93M121.40M95.24M62.65M24.13M16.41M
Long-Term Investments111.78M112.73M81.59M19.54M10.50M9.94M
Long-Term Deferred Tax Assets77.58M88.67M13.00K
Other Long-Term Assets1.03M864.00K730.00K878.00K215.00K204.00K
Total Assets925.99M907.32M808.38M676.81M564.88M295.08M
Accounts Payable27.10M36.56M38.69M38.84M26.85M11.66M
Accrued Expenses44.08M54.29M45.52M37.59M32.08M19.67M
Current Portion of Long-Term Debt9.19M
Current Portion of Leases2.16M1.75M1.34M312.00K
Current Income Taxes Payable2.45M1.61M577.00K
Other Current Liabilities587.00K933.00K1.10M920.00K468.00K
Total Current Liabilities71.18M96.06M88.50M78.11M61.19M41.31M
Long-Term Debt15.80M
Long-Term Leases29.09M30.00M30.04M24.85M7.54M8.80M
Other Long-Term Liabilities136.00K104.00K148.00K1.35M146.00K134.00K
Total Liabilities100.41M126.16M118.69M104.30M68.87M66.04M
Common Stock29.00K29.00K30.00K30.00K29.00K27.00K
Additional Paid-In Capital983.67M927.16M981.04M917.11M820.34M508.46M
Retained Earnings-157.47M-146.49M-291.91M-345.42M-324.27M-279.39M
Comprehensive Income & Other-645.00K464.00K536.00K800.00K-86.00K-55.00K
Total Common Equity825.58M781.16M689.70M572.51M496.01M229.05M
Shareholders' Equity825.58M781.16M689.70M572.51M496.01M229.05M
Total Liabilities & Equity925.99M907.32M808.38M676.81M564.88M295.08M
Total Debt29.09M32.16M31.79M24.85M8.87M34.09M
Net Cash (Debt)291.59M276.11M413.75M435.53M442.54M180.37M
Net Cash Per Share9.949.2813.5514.8615.766.62
Filing Date Shares Outstanding28.91M28.59M29.67M29.59M29.05M27.53M
Total Common Shares Outstanding28.91M28.58M29.74M29.56M29.01M27.42M
Working Capital537.49M487.60M542.30M515.63M468.85M227.23M
Book Value Per Share28.5627.3323.1919.3717.108.35
Tangible Book Value825.58M781.16M689.70M572.51M496.01M229.05M
Tangible Book Value Per Share28.5627.3323.1919.3717.108.35
Machinery54.21M34.10M9.42M8.24M6.08M
Construction In Progress24.38M24.98M33.21M11.86M5.17M
Leasehold Improvements11.77M10.06M2.36M2.06M281.00K

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income135.04M145.42M53.51M-21.15M-44.88M-42.04M
Depreciation & Amortization17.21M13.96M6.55M2.85M1.86M1.22M
Loss (Gain) From Sale of Investments-5.34M-2.89M-8.86M-2.47M-4.00K14.00K
Stock-Based Compensation119.39M130.26M116.01M82.47M51.97M26.48M
Provision & Write-off of Bad Debts200.00K200.00K-768.00K1.61M-63.00K
Other Operating Activities-72.07M-82.59M1.52M2.13M879.00K1.07M
Change in Accounts Receivable34.30M-26.23M-2.60M-30.22M-27.02M-9.24M
Change in Inventory-48.82M-65.17M-46.23M-22.00M5.34M-8.75M
Change in Accounts Payable-22.26M-3.75M604.00K9.30M14.36M4.78M
Change in Other Net Operating Assets-572.00K7.77M10.52M2.14M9.13M6.36M
Operating Cash Flow157.07M116.98M130.25M24.65M11.57M-20.12M
Capital Expenditures-39.98M-38.50M-39.12M-23.63M-9.10M-4.67M
Investment in Securities8.72M59.95M-74.00M-271.19M-10.50M33.81M
Investing Cash Flow-31.26M21.45M-113.12M-294.82M-19.60M29.14M
Long-Term Debt Repaid-24.50M
Net Debt Issued (Repaid)-24.50M
Issuance of Common Stock5.45M14.61M27.77M31.11M259.62M14.95M
Repurchase of Common Stock-110.41M-198.06M-80.17M-17.16M-43.00K
Financing Cash Flow-104.96M-183.45M-52.39M13.95M235.08M14.95M
Foreign Exchange Rate Adjustments-17.00K-310.00K-118.00K164.00K75.00K-19.00K
Net Cash Flow20.83M-45.34M-35.39M-256.06M227.12M23.95M
Free Cash Flow117.09M78.48M91.12M1.02M2.47M-24.79M
Free Cash Flow Margin13.03%8.61%11.35%0.16%0.61%-10.62%
Free Cash Flow Per Share3.992.642.980.040.09-0.91
Levered Free Cash Flow94.64M54.50M62.72M27.62K17.43M-10.69M
Unlevered Free Cash Flow94.72M54.59M62.73M27.62K18.48M-9.36M
Cash Interest Paid137.00K137.00K22.00K2.32M1.89M
Change in Working Capital-37.35M-87.38M-37.71M-40.78M1.81M-6.86M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization1.93B2.68B5.56B6.01B7.28B6.29B
Enterprise Value1.63B2.39B5.17B5.57B6.86B6.11B
Last Close Price68.1092.23185.38203.43251.88230.06
PE Ratio14.4618.43103.82
Forward PE49.1057.14114.37
PS Ratio2.182.946.929.6117.8426.97
PB Ratio2.383.438.0510.4914.6727.48
P/TBV Ratio2.373.438.0510.4914.6727.48
P/FCF Ratio16.7434.1560.965,865.342,942.75
P/OCF Ratio12.4822.9142.65243.63629.04
PEG Ratio9.93
EV/Sales Ratio1.862.626.448.9116.8226.20
EV/EBITDA Ratio23.3936.82121.26
EV/EBIT Ratio30.8246.90143.27
EV/FCF Ratio14.2530.4556.735,436.592,773.55
Debt / Equity Ratio0.040.040.050.040.020.15
Debt / EBITDA Ratio0.370.450.66
Debt / FCF Ratio0.250.410.3524.263.59
Net Debt / Equity Ratio-0.35-0.35-0.60-0.76-0.89-0.79
Net Debt / EBITDA Ratio-4.09-4.25-9.7111.649.684.67
Net Debt / FCF Ratio-2.49-3.52-4.54-425.32-178.957.28
Asset Turnover1.041.061.081.010.950.81
Inventory Turnover0.851.182.164.224.542.59
Quick Ratio5.964.466.097.048.386.02
Current Ratio8.556.087.137.608.666.50
Return on Equity (ROE)17.96%19.77%8.48%-3.96%-12.38%-18.33%
Return on Assets (ROA)3.91%3.71%3.04%-4.05%-6.92%-8.64%
Return on Invested Capital (ROIC)10.10%13.05%16.00%-42.29%-93.19%-106.70%
Return on Capital Employed (ROCE)6.30%6.30%5.00%-6.70%-9.40%-15.70%
Earnings Yield6.91%5.43%0.96%-0.35%-0.62%-0.67%
FCF Yield5.97%2.93%1.64%0.02%0.03%-0.39%
Buyback Yield / Dilution3.84%2.57%-4.24%-4.38%-2.97%-4.56%